Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Redox Regulation and Cancer Therapy

Author(s): A. Süha Yalçın and Betül Karademir

Volume 24 , Issue 44 , 2018

Page: [5232 - 5233] Pages: 2

DOI: 10.2174/138161282444190329154841

[1]
Dawane JS,, Pandit VA. Understanding redox homeostasis and its role in cancer.J Clin Diagn Res. In: 2012; 6: pp. (10)1796-802.
[2]
Schmidt HHHW, Stocker R, Vollbracht C, et al. Antioxidants in translational medicine. Antioxid Redox Signal 2015; 23(14): 1130-43.
[3]
Zhang J,, Wang X,, Vikash V,, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev.2016, 2016.
[http://dx.doi.org/http://dx.doi.org/10.1155/2016/4350965]
[4]
Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov Med 2017; 11(57): 106-14.
[5]
Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, LLeonart ME. Oxidative stress and cancer: an overview. Ageing Res Rev 2013; 12(1): 376-90.
[6]
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med 2010; 49(11): 1603-16.
[7]
Poljsak B, Milisav I. The role of antioxidants in cancer, friends or foes? Curr Pharm Des. 2018; 24(44): 5234-44.
[8]
Schröter D, Höhn A. Role of advanced glycation end-products in carcinogenesis and their therapeutic implications. Curr Pharm Des 2018; 24(44): 5245-1.
[9]
Sari G, Okat Z, Sahin A, Karademir B. Proteasome inhibitors in cancer therapy and their relation to redox regulation. Curr Pharm Des. 2018; 24(44): 5252-67.
[10]
Manda G, Hinescu ME, Neagoe IV, et al. Emerging therapeutic targets in oncologic photodynamic therapy. Curr Pharm Des 2018; 24(44): 5268-95.

© 2022 Bentham Science Publishers | Privacy Policy